There's something compelling about stocks you can own for under $30 per share. For investors with $5,000 or less to put into the market, finding quality stocks at a low price creates an opportunity to build a substantial position that can grow over time.

MET may be worth retaining as higher premiums, cost cuts, strong liquidity and a low forward P/E support growth despite its recent underperformance.

The global mining sector is set for another strong year in 2026, with supply constraints, resilient demand and potential US Federal Reserve rate cuts providing a favorable backdrop for earnings growth and rising share prices, according to analysts at Jefferies. “2026 should be a year of commodity-driven earnings growth for the sector,” Jefferies analysts wrote, highlighting copper and aluminum as the metals with the most upside potential due to widening supply deficits and rising power costs.

Four mega-cap tech stocks still trade at discounts despite a strong 2025 rally, with AI infrastructure and data center demand setting the stage for 2026 upside.

Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.

Centerra Gold Inc. (CGAU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

PagerDuty (PD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CDNS is using the free cash flow to fuel disciplined M&A and steady buybacks amid a competitive EDA landscape.

Global Ship Lease offers deep value and operational excellence, anchored by a $1.9B contract backlog and a focus on mid-sized vessels. GSL maintains sector-leading margins—net income margin of 54.4%—and robust liquidity, supporting a 19% dividend hike and a 7.39% forward yield. Trading at a forward P/E of 3.28x, GSL remains undervalued versus peers, with a conservative price target of $46.49, implying substantial upside.

MIDD rides Food Processing momentum, accretive deals and hefty buybacks as shares jump 35% YTD, far outpacing industry gains on strong global demand.

COST's resilient membership model and digital momentum stack up against TGT's AI push and margin reset in the battle for retail upside.

The iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT ) doesn't have the prettiest chart when you look back at the past few years.

HWM is set to acquire CAM from Stanley Black for $1.8 billion, boosting its aerospace fastening solutions portfolio and market reach.

Meta Platforms (NASDAQ:META) certainly stands out as one of the bigger “deals” to be had in big tech for those looking to play the value side of the AI trade.

U.S. Gold Corp (NASDAQ:USAU) chairman Luke Norman talked with Proactive about completing a $31.2 million capital raise and what the financing means for the company's near-term development plans.

Amgen Inc. ends 2025 on a high note. Thanks to strong sales of Repatha and Imdelltra, it raised its full-year 2025 revenue guidance from $35-$36 billion to $35.8-$36.6 billion. So, sales of Repatha, a cholesterol-lowering medication, were $794 million in Q3, up 40% YoY.

Shares of sports entertainment company TKO Group Holdings, Inc. (TKO) up 24% since first big outlier signal in June.

RBC is seeing accelerating aerospace and defense growth, fueled by strong OEM demand, a rising backlog and robust defense orders.

Federal Signal (FSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Does Flushing Financial (FFIC) have what it takes to be a top stock pick for momentum investors? Let's find out.